Company intelligence / Profile preview

ACLAP

Ownership: Private
Employees: ~250
Development stage: Other

Overview

ACL Digital provides digital transformation, AI-powered analytics, and expert consulting services to pharmaceutical and biotech companies. Their offerings include custom SAS macro tools for data analysis/reporting in clinical trials, electronic data capture solutions, automation of workflows in trials, regulatory process optimization, financial management improvements for sponsors running studies on novel small molecules or rare disease therapies. They do not have their own drug development pipeline or direct clinical results.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Partners with leading technology vendors in digital health/life sciences space.

Beyond the preview

Go deeper on ACLAP.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACLAP.

Explore the full profile